Question 1

Does RA Capital Management own CTNM stock?

Accepted Answer

No. RA Capital Management exited its CTNM (Contineum Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 1,296,012 shares worth $16.9M.

Question 2

How many shares of CTNM does RA Capital Management own?

Accepted Answer

None since Q2 2026, when RA Capital Management exited the position. Its Q1 2026 13F listed 1,296,012 shares worth $16.9M.

Question 3

What is RA Capital Management's CTNM position worth?

Accepted Answer

RA Capital Management's CTNM position was worth $16.9M in its Q1 2026 13F, before the exit in Q2 2026.

Question 4

Is RA Capital Management buying or selling CTNM?

Accepted Answer

In Q2 2026, RA Capital Management exited its entire CTNM position.

Question 5

When did RA Capital Management first buy CTNM?

Accepted Answer

RA Capital Management first reported CTNM in its Q3 2025 13F and listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$16.39	0
2026-Q1	Decreased	1.3M	-40.5%	$16.9M	0.2%	$14.10	0
2025-Q4	Increased	2.2M	+2.7%	$24.9M	0.3%	$11.40	35
2025-Q3	New	2.1M	-	$24.9M	0.3%	$11.82	47

CTNM4 quarters

CTNM
4 quarters